These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9723081)

  • 41. Appropriateness of digoxin level monitoring.
    Mordasini MR; Krähenbühl S; Schlienger RG
    Swiss Med Wkly; 2002 Sep; 132(35-36):506-12. PubMed ID: 12506332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Informatics in medicine: drug monitoring in the elderly. Software for clinical procedures].
    Tamburrini LR
    Minerva Med; 1991 Oct; 82(10):603-12. PubMed ID: 1745372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Confirmed and suspected digoxin intoxications].
    Máiquez Asuero P; Abadín Delgado JA; Jiménez Plata C; Sánchez Romero A; Durán Quintana JA
    An Med Interna; 2003 Aug; 20(8):399-402. PubMed ID: 14516259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma.
    Hashimoto Y; Shibakawa K; Nakade S; Miyata Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):126-32. PubMed ID: 18515196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
    Hsueh PR; Tseng SP; Teng LJ; Ho SW
    Clin Microbiol Infect; 2005 Aug; 11(8):670-3. PubMed ID: 16008621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
    Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.
    DeVore KJ; Hobbs RA
    Pharmacotherapy; 2007 Mar; 27(3):472-5. PubMed ID: 17316159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
    Cohen E; Almog S; Staruvin D; Garty M
    Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multidisciplinary approach to enhance documentation of antibiotic serum sampling.
    Sieradzan R; Fuller AV
    Hosp Pharm; 1995 Oct; 30(10):872, 874, 876-7. PubMed ID: 10151951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change.
    Fitzpatrick F; McGaley T; Rajan L; Crowley R; Turley M; Humphreys H; Smyth E
    J Clin Pathol; 2006 Jun; 59(6):666-7. PubMed ID: 16731612
    [No Abstract]   [Full Text] [Related]  

  • 52. Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients.
    Glintborg B; Hillestrøm PR; Olsen LH; Dalhoff KP; Poulsen HE
    J Clin Pharmacol; 2007 Nov; 47(11):1440-9. PubMed ID: 17962430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
    Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
    J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic sampling from central venous catheters versus peripheral veins.
    McBeth CL; McDonald RJ; Hodge MB
    Pediatr Nurs; 2004; 30(3):200-2. PubMed ID: 15311643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha).
    Tankanow R; Tamer HR; Streetman DS; Smith SG; Welton JL; Annesley T; Aaronson KD; Bleske BE
    J Clin Pharmacol; 2003 Jun; 43(6):637-42. PubMed ID: 12817526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical benefit of interventions driven by therapeutic drug monitoring.
    Rendón A; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
    HIV Med; 2005 Sep; 6(5):360-5. PubMed ID: 16156885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Registration of drug adverse effects at the University of Upsala Hospital].
    Boman G; Claesson C; Göranson P
    Lakartidningen; 1980 May; 77(21):2048-50. PubMed ID: 7401757
    [No Abstract]   [Full Text] [Related]  

  • 58. Digoxin dosing: an alternate approach.
    Jones KW; Howell RR
    J S C Med Assoc; 1995 Mar; 91(3):112-3. PubMed ID: 7739205
    [No Abstract]   [Full Text] [Related]  

  • 59. [Digitoxin].
    Yamamoto K; Iga T
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():945-9. PubMed ID: 8753595
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical application of therapeutic drug monitoring (TDM)].
    Nagasawa K; Nakahara Y
    Nihon Ika Daigaku Zasshi; 1992 Feb; 59(1):2-8. PubMed ID: 1548364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.